Aloin
SIGMA/B6906 - from Aloe barbadensis Miller leaves, ≥97%
Synonym: 1,8-Dihydroxy-10-(β-D-glucopyranosyl)-3-(hydroxymethyl)-9(10H)-anthracenone; 10-β-D-Glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)-9(10H)-anthracenone; Aloin A; Barbaloin
CAS Number: 1415-73-2
Empirical Formula (Hill Notation): C21H22O9
Molecular Weight: 418.39
EC Number: 215-808-0
MDL Number: MFCD00151160
Linear Formula: C21H22O9
Product Type: Chemical
| application(s) | metabolomics vitamins, nutraceuticals, and natural products |
| assay | ≥97% |
| biological source | Aloe barbadensis Miller leaves |
| form | powder |
| InChI | 1S/C21H22O9/c22-6-8-4-10- |
| InChI key | AFHJQYHRLPMKHU-OSYMLPPYSA |
| Quality Level | 200 ![]() |
| SMILES string | OC[C@H]1O[C@H]([C@H](O)[C |
| solubility | methanol: 100 mg/mL, clear to very slightly hazy, light yellow to yellow |
| storage temp. | 2-8°C |
| Application: | Aloin, a natural mixed diastereomer (A/B) anthracycline from aloe plant, may be studied as a chemopreventive factor and antineoplastic agent. Aloin inhibits angiogenesis, enhances melanogenesis and regulates transglutaminase activity. Aloin may be used to assess its activity as a selective phosphodiesterase inhibitor. Aloin A is used as a stabilizer in the preparation of gold and silver nanoparticles. |
| Biochem/physiol Actions: | Purgative activity in rats requires activation by Eubacterium sp. strain BAR or similar intestinal anaerobe, presumably by conversion to aloe-emodin anthrone. |
| Packaging: | 25, 100 mg in poly bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Precautionary statements | P301 + P312 + P330 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 1 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥97% |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352201 |


